Affiliation:
1. From the Department of Biology (A.D.T., K.D.G., I.C.W.), Portland State University, Portland, Ore; and the Departments of Physiology (T.M.L., J.M.D., M.V.C.), Medicine (M.V.C.), and Cell Biology and Neuroscience (S.D.C.), University of South Alabama, Mobile.
Abstract
Ischemic and pharmacological preconditioning can be triggered by an intracellular signaling pathway in which G
i
-coupled surface receptors activate a cascade including phosphatidylinositol 3-kinase, endothelial nitric oxide synthase, guanylyl cyclase, and protein kinase G (PKG). Activated PKG opens mitochondrial K
ATP
channels (mitoK
ATP
) which increase production of reactive oxygen species. Steps between PKG and mitoK
ATP
opening are unknown. We describe effects of adding purified PKG and cGMP on K
+
transport in isolated mitochondria. Light scattering and respiration measurements indicate PKG induces opening of mitoK
ATP
similar to K
ATP
channel openers like diazoxide and cromakalim in heart, liver, and brain mitochondria. This effect was blocked by mitoK
ATP
inhibitors 5-hydroxydecanoate, tetraphenylphosphonium, and glibenclamide, PKG-selective inhibitor KT5823, and protein kinase C (PKC) inhibitors chelerythrine, Ro318220, and PKC-ε peptide antagonist εV
1-2
. MitoK
ATP
are opened by the PKC activator 12-phorbol 13-myristate acetate. We conclude PKG is the terminal cytosolic component of the trigger pathway; it transmits the cardioprotective signal from cytosol to inner mitochondrial membrane by a pathway that includes PKC-ε.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Physiology
Cited by
250 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献